Sabby Management’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-441
Closed -$254K 374
2015
Q4
$254K Buy
441
+128
+41% +$89.7K 0.01% 273
2015
Q3
$278K Sell
313
-1,554
-83% -$1.42M 0.01% 329
2015
Q2
$1.92M Buy
+1,867
New +$2.19M 0.07% 166
2014
Q4
Sell
-240
Closed -$347K 297
2014
Q3
$294 Buy
+240
New +$345K 0.01% 210
2014
Q1
Sell
-529
Closed -$683K 284
2013
Q4
$683K Buy
529
+71
+16% +$113K 0.04% 138
2013
Q3
$921K Buy
+458
New +$851K 0.06% 127

Other funds holding HSTO

Sabby Management's HSTO Position: Q1 2016 in Review

Sabby Management sold out of Histogen Inc. Common Stock (HSTO) in Q1 2016, closing a stake of 441 shares — an estimated $254K sold.

Sabby Management first reported a position in HSTO in Q3 2013 and held it in 6 quarters. The position peaked at $1.92M in Q2 2015. 32 funds tracked by Wall St. Rank hold HSTO as of Q1 2016.

  • Sabby Management reported no remaining Histogen Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • Sabby Management sold 441 Histogen Inc. Common Stock shares in Q1 2016, an estimated $254K.
  • Sabby Management first reported a position in Histogen Inc. Common Stock in Q3 2013 and held it in 6 quarters.
  • Sabby Management's Histogen Inc. Common Stock position peaked at $1.92M in Q2 2015.
  • 32 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q1 2016.

Based on Sabby Management's 13F filing for Q1 2016, filed 13 May 2016.